tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Graft Occlusion, Vascular D006083 11 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Bacterial Infections D001424 21 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Mouth Diseases D009059 5 associated lipids
Meningococcal Infections D008589 3 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Grinyó JM and Petruzzelli S Once-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantations. 2014 Expert Rev Clin Immunol pmid:25407098
Hattori Y et al. Influence of cytochrome P450 3A5 polymorphisms on viral infection incidence in kidney transplant patients treated with tacrolimus. 2014 Transplant. Proc. pmid:24656015
Uchida J et al. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients. 2014 Transplant. Proc. pmid:24656005
Zaltzman JS et al. A randomized cross-over comparison of short-term exposure of once-daily extended release tacrolimus and twice-daily tacrolimus on renal function in healthy volunteers. 2014 Transpl. Int. pmid:25160518
Misra DP et al. Pulmonary co-infection with Nocardia and Aspergillus in a patient with adult-onset Still's disease receiving steroids and tacrolimus. 2014 BMJ Case Rep pmid:25398925
Weng LC et al. Association between use of FK506 and prevalence of post-transplantation diabetes mellitus in kidney transplant patients. 2014 Transplant. Proc. pmid:24656004
Takahashi K et al. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan. 2014 Transplant. Proc. pmid:24655975
Wu MJ et al. Reduced variability of tacrolimus trough level in once-daily tacrolimus-based Taiwanese kidney transplant recipients with high-expressive genotype of cytochrome P450 3A5. 2014 Transplant. Proc. pmid:24655974
Jun H et al. Experiences on conversion to once-daily Advagraf and sirolimus combination in stable kidney recipients. 2014 Transplant. Proc. pmid:24655973
Cusinato DA et al. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients. 2014 Br J Clin Pharmacol pmid:24528196
Gérard C et al. Determination of the most influential sources of variability in tacrolimus trough blood concentrations in adult liver transplant recipients: a bottom-up approach. 2014 AAPS J pmid:24526611
Leung EK et al. Clinical evaluation of the QMS® Tacrolimus immunoassay. 2014 Clin. Chim. Acta pmid:24518359
McCormack PL Extended-release tacrolimus: a review of its use in de novo kidney transplantation. 2014 Drugs pmid:25352392
Qi R et al. FK506 inhibits the mice glomerular mesangial cells proliferation by affecting the transforming growth factor-β and Smads signal pathways. 2014 Ren Fail pmid:24512120
Mocchegiani F et al. Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. 2014 Ann. Transplant. pmid:25347718
Filler G Finding the optimal therapeutic window for tacrolimus. 2014 Pediatr Transplant pmid:25345999
Okada K et al. [Single institution experience of HLA-haploidentical hematopoietic stem cell transplantation for children: current problems and perspective]. 2014 Rinsho Ketsueki pmid:24492043
Thölking G et al. The tacrolimus metabolism rate influences renal function after kidney transplantation. 2014 PLoS ONE pmid:25340655
Méndez A et al. Pharmacokinetic study of conversion from tacrolimus twice-daily to tacrolimus once-daily in stable lung transplantation. 2014 Transplantation pmid:24492423
Moss MC et al. Lithium use for bipolar disorder post renal transplant: is mood stabilization without toxicity possible? 2014 Transplantation pmid:24492429
Lipson EJ et al. Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma. 2014 J. Clin. Oncol. pmid:24493726
Hinchliffe E et al. Therapeutic drug monitoring of ciclosporin A and tacrolimus in heart lung transplant patients using dried blood spots. 2014 Ann. Clin. Biochem. pmid:23939194
Pulsipher MA et al. The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. 2014 Blood pmid:24497539
Verma M et al. Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity. 2014 J. Surg. Res. pmid:24485875
Torres IB et al. The Interplay between inflammation and fibrosis in kidney transplantation. 2014 Biomed Res Int pmid:24991565
Carr L et al. Calcineurin activity assay measurement by liquid chromatography-tandem mass spectrometry in the multiple reaction monitoring mode. 2014 Clin. Chem. pmid:24281780
Isoda K et al. The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases. 2014 Intern. Med. pmid:24990333
Wada A et al. Ribosome display and photo-cross-linking techniques for in vitro identification of target proteins of bioactive small molecules. 2014 Anal. Chem. pmid:24380432
Buendia JA et al. Effects of combinational CYP3A5 6986A>G polymorphism in graft liver and native intestine on the pharmacokinetics of tacrolimus in liver transplant patients: a meta-analysis. 2014 Ther Drug Monit pmid:24378577
Eid L et al. Late acute rejection: incidence, risk factors, and effect on graft survival and function. 2014 Pediatr Transplant pmid:24372967
Peng ZG and Tian J Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients. 2014 Clin Transpl pmid:26281147
Filler G et al. Similar MPA exposure on modified release and regular tacrolimus. 2014 Ther Drug Monit pmid:24365986
Jain A et al. Delayed introduction of tacrolimus postliver transplant with intravenous mycophenolate mofetil preserves renal function without incurring rejection. 2014 Transplantation pmid:25285953
Gounden V and Soldin SJ Tacrolimus measurement: building a better immunoassay. 2014 Clin. Chem. pmid:24415738
Basu B Ofatumumab for rituximab-resistant nephrotic syndrome. 2014 N. Engl. J. Med. pmid:24670185
Takeuchi T et al. Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis. 2014 Mod Rheumatol pmid:24261753
Fukushima A et al. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. 2014 Br J Ophthalmol pmid:24695688
Czubkowski P et al. Cardiovascular risk factors after conversion from cyclosporine to tacrolimus in children after liver transplantation. 2014 Ann. Transplant. pmid:25409773
Protic M et al. The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. 2014 J Crohns Colitis pmid:24908178
Hayashi K et al. Delayed false elevation of circulating tacrolimus concentrations after cord blood transplantation in a patient with myelodysplastic syndrome. 2014 Intern. Med. pmid:25400189
Sugiyama K et al. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor. 2014 Exp Clin Transplant pmid:24907718
Lankarani KB et al. New onset diabetes and impaired fasting glucose after liver transplant: risk analysis and the impact of tacrolimus dose. 2014 Exp Clin Transplant pmid:23902591
Spagnoletti G et al. Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up. 2014 Transplant. Proc. pmid:25242756
Schellekens J et al. The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity? 2014 Transpl. Immunol. pmid:25240735
Liu FL et al. FKBP12 regulates the localization and processing of amyloid precursor protein in human cell lines. 2014 J. Biosci. pmid:24499793
Parks AC et al. Long-term clearance of linear porokeratosis with tacrolimus, 0.1%, ointment. 2014 JAMA Dermatol pmid:24553841
Xu C et al. Tacrolimus reversibly reduces insulin secretion, induces insulin resistance, and causes islet cell damage in rats. 2014 Int J Clin Pharmacol Ther pmid:24755137
Ichinose K et al. [Rare case of systemic lupus erythematosus with encapsulating peritoneal sclerosis during hemodialysis]. 2014 Nihon Jinzo Gakkai Shi pmid:24730352
Schmid S et al. Volatility of serum creatinine relative to tacrolimus levels predicts kidney transplant rejection. 2014 Ann. Transplant. pmid:25123847
Caraveo G et al. Calcineurin determines toxic versus beneficial responses to α-synuclein. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25122673
Gajanayake T et al. A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. 2014 Sci Transl Med pmid:25122638
Thorat A et al. Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients. 2014 Biomed Res Int pmid:25121091
Griffith RD et al. Cells to surgery quiz: September 2014. 2014 J. Invest. Dermatol. pmid:25120152
García-García B et al. Frosch' surface microscopy score for the assessment of steroid-induced atrophy. 2014 Arch. Dermatol. Res. pmid:24402286
Gionchetti P and Rizzello F IBD. Sequential rescue therapy in steroid-refractory ulcerative colitis. 2014 Nat Rev Gastroenterol Hepatol pmid:25023033
Van der Hauwaert C et al. Expression profiles of genes involved in xenobiotic metabolism and disposition in human renal tissues and renal cell models. 2014 Toxicol. Appl. Pharmacol. pmid:25036895
Zivčić-Ćosić S et al. Immune reactivity of renal transplant recipients receiving interleukin-2 receptor antagonists during the early posttransplant period. 2014 Int Urol Nephrol pmid:23515930
Helenius-Hietala J et al. Oral mucosal health in liver transplant recipients and controls. 2014 Liver Transpl. pmid:24142471
Li Q et al. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection. 2014 Eur J Pharm Sci pmid:24905830
Farkas K et al. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis. 2014 Expert Rev Gastroenterol Hepatol pmid:24738535
Hamilton BK and Kalaycio M Maximizing the benefits of mycophenolate mofetil as graft-versus-host disease prophylaxis. 2014 Biol. Blood Marrow Transplant. pmid:25065905
Shimizu M et al. Treatment of refractory polyarticular juvenile idiopathic arthritis with tacrolimus. 2014 Rheumatology (Oxford) pmid:25065006
Dai YJ et al. Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris. 2014 Asian Pac J Trop Med pmid:25063291
Oda K and Yamano K Effect of telaprevir on the metabolism and hepatic uptake of tacrolimus (FK506). 2014 Biopharm Drug Dispos pmid:25059890
Garriga-Companys S and Labrador-Horrillo M [Chronic spontaneous urticaria]. 2014 Med Clin (Barc) pmid:24120109
Kurzawski M et al. Impact of PPARA and POR polymorphisms on tacrolimus pharmacokinetics and new-onset diabetes in kidney transplant recipients. 2014 Pharmacogenet. Genomics pmid:24921414
Marits P et al. Evaluation of T and B lymphocyte function in clinical practice using a flow cytometry based proliferation assay. 2014 Clin. Immunol. pmid:24909732
Uesugi M et al. Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation. 2014 Pharmacogenet. Genomics pmid:24911663
Di Stasio D et al. Oral lichen planus: a narrative review. 2014 Front Biosci (Elite Ed) pmid:24896212
Al-Harbi NO et al. Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue. 2014 Biomed Res Int pmid:24987695
Nikitin AV [Mechanisms of nephrotoxic action of immunodepressants, calcineurine inhibitors]. 2014 Antibiot. Khimioter. pmid:25051716
Sun J et al. [A preliminary study on the biological characteristics and function of tolerogenic dendritic cells induced by tacrolimus]. 2014 Zhonghua Xue Ye Xue Za Zhi pmid:24985179
Saracino A et al. Multidrug-resistance 1 gene single-nucleotide polymorphisms do not influence long-term graft survival after kidney transplantation. 2014 Transplant. Proc. pmid:25242754
Lan X et al. Efficacy of immunosuppression monotherapy after liver transplantation: a meta-analysis. 2014 World J. Gastroenterol. pmid:25232269
Nath PR et al. Immunophilins control T lymphocyte adhesion and migration by regulating CrkII binding to C3G. 2014 J. Immunol. pmid:25225668
Ji SM et al. Retrospective evaluation of the effect of mycophenolate mofetil dosage on survival of kidney grafts based on biopsy results. 2014 Transplant. Proc. pmid:25498056
Hebral AL et al. Pregnancy after kidney transplantation: outcome and anti-human leucocyte antigen alloimmunization risk. 2014 Nephrol. Dial. Transplant. pmid:24914091
Zhu H et al. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo. 2014 Mol Med Rep pmid:24912495
Van Laecke S et al. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial. 2014 Transpl. Int. pmid:24909487
Hayes D et al. Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation. 2014 Pediatr. Neurol. pmid:24405697
Hosohata K et al. Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients. 2014 Drug Metab. Pharmacokinet. pmid:23955548
Trkulja V et al. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data. 2014 Ther Drug Monit pmid:24518562
Foroncewicz B et al. Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis. 2014 Ann. Transplant. pmid:25163829
Hayashi T and Harada N Post-translational dual regulation of cytochrome P450 aromatase at the catalytic and protein levels by phosphorylation/dephosphorylation. 2014 FEBS J. pmid:25158681
Savikko J et al. Different effects of tacrolimus and cyclosporine on PDGF induction and chronic allograft injury: evidence for improved kidney graft outcome. 2014 Transpl. Immunol. pmid:25158212
Kern G et al. Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. 2014 PLoS ONE pmid:24816588
Sánchez L et al. Topical tacrolimus for recurrent penile Crohn's disease. 2014 J Crohns Colitis pmid:24815787
Reynolds BC et al. Use of belatacept to maintain adequate early immunosuppression in calcineurin-mediated microangiopathic hemolysis post-renal transplant. 2014 Pediatr Transplant pmid:24815506
Kim YE and Eun SC Effect of FK506 ointment (Protopic) on rat skin allograft model. 2014 Transplant. Proc. pmid:24815165
Lee KM and Eun SC Experimental canine facial transplantation. 2014 Transplant. Proc. pmid:24815162
Wang J and Fan H [Assessment of P70S6 kinase phosphorylation after liver transplantation by phospho-flow cytometry]. 2014 Zhonghua Yi Xue Za Zhi pmid:25623311
Osmola-Mańkowska A et al. Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography. 2014 Eur Rev Med Pharmacol Sci pmid:25555886
Ishikawa Y and Bächinger HP A substrate preference for the rough endoplasmic reticulum resident protein FKBP22 during collagen biosynthesis. 2014 J. Biol. Chem. pmid:24821723
Upadhyay V et al. Rapid and sensitive UPLC-MS-MS determination of tacrolimus in Wistar rats and human blood. 2014 J Chromatogr Sci pmid:23264321
Hilgers M and Megahed M [Oral lichen planus. Insight into the pathogenesis and therapeutic options]. 2014 Hautarzt pmid:24722910
Shipkova M et al. Multi-center analytical evaluation of a novel automated tacrolimus immunoassay. 2014 Clin. Biochem. pmid:24721684
Lin BW et al. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye. 2014 Invest. Ophthalmol. Vis. Sci. pmid:25491293
Hsiao FY and Hsu WW Epidemiology of post-transplant malignancy in Asian renal transplant recipients: a population-based study. 2014 Int Urol Nephrol pmid:24009082
Földes G et al. Immunosuppressive agents modulate function, growth, and survival of cardiomyocytes and endothelial cells derived from human embryonic stem cells. 2014 Stem Cells Dev. pmid:24192059
Kharfan-Dabaja M et al. Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation. 2014 Cochrane Database Syst Rev pmid:25061777